CLINICAL PHASE-I PILOT-STUDY OF THE ALKYL LYSOPHOSPHOLIPID DERIVATIVE ET-18-OCH3

[1] ANDREESEN M, 1979, IMMUNOBIOLOGY, V156, P498

[2] ARNOLD D, 1967, LIEBIGS ANN CHEM, V709, P234

[3] CYTOGENETIC EFFECTS OF AN ALKYL-LYSOPHOSPHOLIPID DERIVATIVE IN HUMAN PERIPHERAL LYMPHOCYTES EXPOSED INVITRO AND INVIVO [J]. MUTATION RESEARCH, 1983, 121 (3-4): : 225 - 231

[4] BERDEL WE, 1981, ANTICANCER RES, V1, P345

[5] BERDEL WE, 1982, CANCER, V50, P2011, DOI 10.1002/1097-0142(19821115)50:10<2011::AID-CNCR2820501006>3.0.CO

[6] 2-K

[7] BERDEL WE, 1985, ENTWICKLUNG PRUFUNG, P215

[8] BERDEL WE, 1985, PHOSPHOLIPIDS CELLUL, V2, P41

[9] EIBL H, 1967, LIEBIGS ANN CHEM, V709, P226

[10] LEE TC, 1985, PHOSPHOLIPIDS CELLUL, V2, P1

[1] ANDREESEN M, 1979, IMMUNOBIOLOGY, V156, P498

[2] ARNOLD D, 1967, LIEBIGS ANN CHEM, V709, P234

[3] CYTOGENETIC EFFECTS OF AN ALKYL-LYSOPHOSPHOLIPID DERIVATIVE IN HUMAN PERIPHERAL LYMPHOCYTES EXPOSED INVITRO AND INVIVO [J]. MUTATION RESEARCH, 1983, 121 (3-4): : 225 - 231

[4] BERDEL WE, 1981, ANTICANCER RES, V1, P345

[5] BERDEL WE, 1982, CANCER, V50, P2011, DOI 10.1002/1097-0142(19821115)50:10<2011::AID-CNCR2820501006>3.0.CO

[6] 2-K

[7] BERDEL WE, 1985, ENTWICKLUNG PRUFUNG, P215

[8] BERDEL WE, 1985, PHOSPHOLIPIDS CELLUL, V2, P41

[9] EIBL H, 1967, LIEBIGS ANN CHEM, V709, P226

[10] LEE TC, 1985, PHOSPHOLIPIDS CELLUL, V2, P1